The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Endothelial lipase is a major genetic determinant for high-density lipoprotein concentration, structure, and metabolism
Abstract
High-density lipoprotein (HDL) protects against atherosclerosis. Endothelial lipase (EL) has been postulated to be involved in lipoprotein, and possibly HDL, metabolism, yet the evidence has been scarce and conflicting. We have inactivated EL in mice by gene targeting. EL −/− mice have elevated plasma and HDL cholesterol, and increased apolipoproteins A-I and E. NMR analysis reveals an abundance of large HDL particles. There is down-regulation of the transcripts for phospholipid transfer protein, but up-regulation of those for hepatic lipase and lipoprotein lipase. Plasma lecithin:cholesterol acyltransferase is unchanged despite an increase in hepatic mRNA; lecithin:cholesterol acyltransferase activity toward endogenous EL −/− substrate is, however, reduced by 50%. HDL clearance is decreased in EL −/− mice; both the structure of HDL and the presence of EL are factors that determine the rate of clearance. To determine EL's role in humans, we find a significant association between a single-nucleotide polymorphism 584C/T in the EL ( LIPG ) gene and HDL cholesterol in a well characterized population of 372 individuals. We conclude that EL is a major determinant of HDL concentration, structure, and metabolism in mice, and a major determinant of HDL concentration in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
EL belongs to the same lipase family as LPL, but targets phospholipids on the shell of high-density lipoproteins (HDL), leading to decreased HDL levels.
“EL belongs to the same lipase family as LPL, but targets phospholipids on the shell of high-density lipoproteins (HDL), leading to decreased HDL levels (119–122).”
From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [120]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
Human plasma phospholipid transfer protein causes high density lipoprotein conversion.
Jauhiainen, M., Metso, J., Pahlman, R., Blomqvist, S., van Tol, A., & Ehnholm, C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53575-4 · Cited by 342
Flagged first, then by citations
Research works printed but not linked: 31
- 10.1161/01.CIR.85.6.2025 · DOI
- 10.1016/S0022-2275(20)39898-9 · DOI · Paper page
- 10.1042/bj2940829 · DOI
- 10.1111/j.1440-1681.1997.tb01821.x · DOI
- 10.1172/JCI5006 · DOI
- P Tretjakovs, U Kalnins, I Dabina, I Dinne, A Erglis, I Kumsars, A Jurka Med Sci Monit 6, 507–511 (2000).
- 10.1038/7766 · DOI · Paper page
- 10.1074/jbc.274.20.14170 · DOI
- 10.1016/S0022-2275(20)30466-1 · DOI · Paper page
- 10.1006/bbrc.2000.2747 · DOI
- 10.1161/01.CIR.0000028423.07623.6A · DOI
- 10.1074/jbc.274.10.6051 · DOI
- 10.1016/S0022-2275(20)33361-7 · DOI
- 10.2337/diabetes.51.6.1949 · DOI
- 10.1016/S0022-2275(20)38100-1 · DOI
- 10.1016/0021-9150(85)90058-9 · DOI
- 10.1016/0003-2697(83)90672-3 · DOI
- 10.1172/JCI116375 · DOI
- 10.1074/jbc.274.47.33398 · DOI
- 10.1016/S0197-2456(96)00178-X · DOI
- 10.1016/S0021-9258(19)49431-3 · DOI
- 10.1172/JCI5578 · DOI
- 10.1074/jbc.272.43.27393 · DOI
- 10.1016/0005-2760(84)90328-X · DOI
- 10.1139/o89-056 · DOI
- 10.1016/S0002-9149(97)00346-9 · DOI
- 10.1016/S0735-1097(00)00918-9 · DOI
- 10.1161/hh0901.090301 · DOI
- 10.1161/01.CIR.96.7.2137 · DOI
- 10.1001/jama.285.12.1585 · DOI
- 10.1194/jlr.R200011-JLR200 · DOI
Cited by
Sorted by citations
Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300019-jlr200 · Cited by 1,481
Mandard, S., Zandbergen, F., van Straten, E., Wahli, W., Kuipers, F., Müller, M., & Kersten, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m506519200 · Cited by 433
The metabolism and anti-atherogenic properties of HDL
Rye, K.-A., Bursill, C. A., Lambert, G., Tabet, F., & Barter, P. J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800034-jlr200 · Cited by 331
Shimamura, M., Matsuda, M., Yasumo, H., Okazaki, M., Fujimoto, K., Kono, K., Shimizugawa, T., Ando, Y., Koishi, R., Kohama, T., et al. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000252827.51626.89 · Cited by 297
Obesity-Related Changes in High-Density Lipoprotein Metabolism and Function
Stadler, J. T., & Marsche, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238985 · Cited by 200
Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8
Sylvers-Davie, K. L., & Davies, B. S. J. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00195.2021 · Cited by 154
Frikke-Schmidt, R. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.06.005 · Cited by 94
High-density lipoprotein-related cholesterol metabolism in Alzheimer's disease
Pedrini, S., Chatterjee, P., Hone, E., & Martins, R. N. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15170 · Cited by 22
Metadata
- Authors
- Ma, K., Cilingiroglu, M., Otvos, J. D., Ballantyne, C. M., Marian, A. J., & Chan, L.
- Affiliations
- Section of Endocrinology and Metabolism, Departments of Medicine and Molecular and Cellular Biology, and Section of Cardiology and Atherosclerosis, Department of Medicine, Baylor College of Medicine and Methodist Hospital, Houston, TX 77030; LipoScience, Raleigh, NC 27610; and St. Luke's Episcopal Hospital, Houston, TX 77030
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-02-24
- Volume
- 100
- Issue
- 5
- Pages
- 2748-2753
- ISSN
- 0027-8424
- 1091-6490
- Cited by
- 189
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review